P53-Armed Oncolytic Virotherapy Promotes the Efficacy of PD1 Blockade in Murine Osteosarcoma Tumors

20250 citationsJournal Articlehybrid Open Access

Authors

Our results suggest that P53-armed OBP-702 is a promising agent for improving the antitumor effect of PD1 blockade in treating invasive OS.

Zero hunger

Published in: Anticancer Research

Volume 46, Issue 1, pp. 69-84

Field-Weighted Citation Impact: 0.00